View Older Stories View More Recent Stories

May 5, 2021 04:01PM Personalis Reports First Quarter 2021 Financial Results
Apr 8, 2021 04:07PM Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
Mar 29, 2021 04:03PM Personalis Announces Collaboration with MapKure to Use Personalis’ NeXT Platform™ for Clinical Trials and Companion Diagnostic Development
Mar 8, 2021 05:00PM Personalis Announces Changes to its Board of Directors
Feb 25, 2021 04:01PM Personalis Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 17, 2021 09:01AM Natera and Personalis Partner for Personalized Monitoring in Oncology
Feb 17, 2021 09:00AM Natera and Personalis Partner for Personalized Monitoring in Oncology
Feb 8, 2021 05:13PM Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources Officer
Jan 11, 2021 04:01PM Personalis Reports Preliminary Fourth Quarter 2020 Revenue
Dec 28, 2020 04:01PM Personalis to Present at the 23rd Annual Needham Virtual Growth Conference
Dec 17, 2020 09:09AM Personalis Announces the Launch of NEOPS™, a Neoantigen-based Composite Biomarker for Cancer Immunotherapy Response
Dec 17, 2020 09:07AM Personalis Announces the Launch of SHERPA™ for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
Dec 9, 2020 04:07PM Personalis Announces Delivery of the 100,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
Nov 18, 2020 08:00AM Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event
Nov 16, 2020 09:00AM Personalis® to Present at the AMP Annual Meeting 2020
Nov 9, 2020 04:12PM Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
Nov 5, 2020 04:01PM Personalis Reports Third Quarter 2020 Financial Results
Oct 27, 2020 04:01PM Personalis to Participate in Upcoming Investor Conferences
Oct 22, 2020 04:01PM Personalis to Announce Third Quarter 2020 Financial Results on November 5, 2020
Oct 15, 2020 09:02AM Personalis to Participate in Immuno Series US Virtual Meeting
Oct 1, 2020 01:20PM Personalis, Inc. to Present at IO Combinations 360˚
Sep 29, 2020 04:05PM Personalis to Participate in Digital World CB & CDx Meeting
Sep 17, 2020 08:07AM Personalis, Inc. (PSNL) Receives Contract Extension and New Task Order From the VA’s Million Veteran Program
Sep 17, 2020 08:03AM Personalis Receives Contract Extension and New Task Order From the VA’s Million Veteran Program – Total Awarded to Date Now $175M
Sep 15, 2020 04:01PM Personalis Strengthens Commercial Team with the Appointment of New Head of Population Genomics
Sep 2, 2020 04:01PM Personalis to Participate in Upcoming Investor Conferences
Aug 12, 2020 04:01PM Personalis to Participate at the Needham Virtual Cancer Diagnostics 1x1 Conference
Aug 6, 2020 04:01PM Personalis Reports Second Quarter 2020 Financial Results
Aug 3, 2020 08:17AM Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy Platform
Jul 23, 2020 04:01PM Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020
Jul 16, 2020 05:15PM Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 16, 2020 08:32AM Personalis Further Expands Leadership Team With Appointment of Leslie Grab, VP of Intellectual Property and John Lyle, VP of Assay Research and Development
Jun 24, 2020 08:00AM Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP
Jun 22, 2020 08:00AM Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting
Jun 18, 2020 06:15PM Personalis to Participate in European Association for Cancer Research (EACR) 2020 Virtual Congress
Jun 16, 2020 01:00PM Personalis to Present at the Precision Breast Cancer Summit
Jun 16, 2020 08:00AM Personalis Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 10, 2020 04:05PM Personalis Announces a Partnership with Berry Genomics for China Expansion
Jun 2, 2020 08:00AM Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics
May 29, 2020 11:08AM Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting
May 7, 2020 04:01PM Personalis Reports First Quarter 2020 Financial Results
May 5, 2020 02:00PM Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel
Apr 29, 2020 04:05PM Personalis to Participate at Upcoming Investor Conferences
Apr 29, 2020 12:00PM Personalis Announces Renewed Clinical Laboratory Accreditation from College of American Pathologists
Apr 23, 2020 04:05PM Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020
Apr 21, 2020 11:31AM Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Apr 21, 2020 03:00AM Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Apr 14, 2020 11:45AM Personalis, Inc. Expands Genomics Portfolio Across Disease Areas With Launch of Pharma Research Solutions for Use in Early Drug Discovery and Preclinical Studies
Mar 31, 2020 04:05PM Personalis to Participate at the 19th Annual Needham Virtual Healthcare Conference
Mar 25, 2020 04:01PM Personalis Reports Fourth Quarter and Full Year 2019 Financial Results
View More Recent Stories View Older Stories